🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

4,196 results for “GE” Clear

  1. bbT369

    Regeneron UK Limited

    Diffuse Large B Cell Lymphoma (DLBCL)

    phase 1 mab terminated

    1 trial

  2. cemiplimab

    Regeneron UK Limited

    Relapsed/Refractory Aggressive B-Cell Lymphoma

    phase 1 small molecule active

    1 trial

  3. clinical trial to determine the feasibility and safety of the mesenchymal stem cells use in women over 50 years of age with urinary incontinencee

    The George Institute

    Stress or mixed urinary incontinence in women over 50 years of age not responding to conventional treatments

    phase 1 other active

    1 trial

  4. colchicine

    Ultragenyx UK Limited

    Cirrhosis

    phase 1 small molecule active

    1 trial

  5. cyclophosphamide

    Ultragenyx UK Limited

    Multiple Sclerosis

    phase 1 small molecule completed

    1 trial

  6. delta 9 tetrahydrocannabinol

    BRIGHT MINDS BIOSCIENCES INC.

    COMT Gene Polymorphism

    phase 1 small molecule completed

    1 trial

  7. etrumadenant

    Arcus Biosciences

    GastroEsophageal Cancer

    phase 1 small molecule completed

    1 trial

  8. fRPE cells

    The First People's Hospital of Lianyungang

    Age Related Macular Degeneration

    phase 1 small molecule active

    1 trial

  9. filgrastim

    Ultragenyx UK Limited

    Fanconi's Anemia

    phase 1 small molecule active

    1 trial

  10. gene therapy

    Ultragenyx UK Limited

    Familial Hypercholesterolemia

    phase 1 other completed

    1 trial

  11. haploid allogeneic NK cell therapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Acute Myeloid Leukemia

    phase 1 mab active

    1 trial

  12. human HER2-targeted CAR-M cells

    The First People's Hospital of Lianyungang

    Gastric Cancer

    phase 1 mab active

    1 trial

  13. iridoid enriched mixed fruit beverage

    International Peace Maternity and Child Health Hospital

    Oxidative Stress

    phase 1 other completed

    1 trial

  14. limonene containing massage oil

    United Therapeutics Europe Ltd

    Breast Cancer

    phase 1 other completed

    1 trial

  15. linvoseltamab

    Regeneron UK Limited

    Food Allergy

    phase 1 small molecule active

    1 trial

  16. medroxyprogesterone acetate

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    1 trial

  17. monoclonal antibody M-T412

    Ultragenyx UK Limited

    Multiple Sclerosis

    phase 1 small molecule completed

    1 trial

  18. nesvacumab (REGN910/ SAR307746)

    Regeneron UK Limited

    Solid Tumors

    phase 1 small molecule completed

    2 trials

  19. pomalidomide

    Celgene Europe Limited

    Multiple Myeloma in Relapse

    phase 1 small molecule completed

    1 trial

  20. recombinant adenovirus containing the ornithine transcarbamylase gene

    Ultragenyx UK Limited

    Ornithine Transcarbamylase Deficiency Disease

    phase 1 gene therapy terminated

    1 trial

  21. rilonacept (IL-1 Trap)

    Regeneron UK Limited

    Systemic Juvenile Idiopathic Arthritis

    phase 1 small molecule completed

    1 trial

  22. sevasemten

    Edgewise Therapeutics

    Healthy Subjects

    phase 1 small molecule completed

    1 trial

  23. sphingosine kinase-2 inhibitor ABC294640

    Apogee Therapeutics

    Pancreatic Cancer

    phase 1 small molecule completed

    1 trial

  24. von Willebrand factor

    Ultragenyx UK Limited

    Von Willebrand's Disease

    phase 1 small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources